Lidorex
Lidorex is an FDA drug label for the active ingredient LIDOCAINE HCL manufactured by PureTek Corporation administered by TOPICAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20230111.
Generic: LIDOCAINE HCL
Manufacturer: PureTek Corporation
Product Type: HUMAN PRESCRIPTION DRUG
Route: TOPICAL
Dosage Form:
NDC: 59088-475
Application:
Effective: 20230111
Indications & Usage
INDICATIONS: For temporary relief of pain and itching associated with minor burns, sunburn, minor cuts, scrapes, insect bites, and minor skin irritation.
Dosage & Administration
DOSAGE AND ADMINISTRATION: Apply a thin film to the affected area two or three times daily or as directed by a physician.
Contraindications
CONTRAINDICATIONS: Tuberculous or fungal lesions of skin vaccinia, varicella, and acute herpes simplex and in persons who have shown hypersensitivity to any of its components. Lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.
Warnings
WARNINGS: For external use only. Not for ophthalmic use. Keep out of reach of children.
Adverse Reactions
ADVERSE REACTIONS: During or immediately after treatment, the skin at the site of treatment may develop erythema or edema or may be the locus of abnormal sensation.
More from same ingredient
LidoStat
Clinical Therapeutic Solutions
Lidogel
PureTek Corporation
Totally Fun After Sun
MJ Products Association, LLC